• Je něco špatně v tomto záznamu ?

Antipsychotic Drug Interactions and Mortality Among Nursing Home Residents With Cognitive Impairment

R. Liperoti, F. Sganga, F. Landi, E. Topinkova, MD. Denkinger, HG. van der Roest, AD. Foebel, H. Finne-Soveri, R. Bernabei, G. Onder,

. 2017 ; 78 (1) : e76-e82.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17023333

OBJECTIVE: Among elderly individuals with dementia, the use of antipsychotics has been associated with serious adverse events including ischemic stroke and death. Multiple medications can interact with antipsychotics and increase the risk of such adverse events. The purpose of this retrospective, longitudinal cohort study was to estimate the prevalence of potential antipsychotic drug interactions and their effect on increasing the risk of death among cognitively impaired elderly individuals treated with antipsychotics. METHODS: We conducted a retrospective longitudinal cohort study in 59 nursing homes of 7 European Union countries and Israel. The study was conducted during the years 2009 to 2011. Participants were cognitively impaired individuals aged 65 years or older residing in the participating nursing homes and being treated with antipsychotics (N = 604). Risk of death associated with potential antipsychotic drug interactions was the main outcome. The inter-Resident Assessment Instrument for Long Term Care Facilities (interRAI LTCF) was used to assess participants. Follow-up time was 12 months. RESULTS: The prevalence of potential antipsychotic drug interactions was 46.0%. Antipsychotic drug interactions were associated with higher mortality (incidence rate of 0.26 per person-year in the antipsychotic drug-interaction group versus 0.17 per person year in the no antipsychotic drug-interaction group). After adjusting for potential confounders, risk of death was higher in the group of residents with potential antipsychotic drug interactions relative to those unexposed to such interactions (hazard ratio = 1.71; 95% CI, 1.15-2.54). CONCLUSIONS: Part of the observed excess risk of death associated with the use of antipsychotic medications in elderly individuals with cognitive impairment may be attributable to antipsychotic drug interactions. Antipsychotics should be used with extreme caution especially among those individuals receiving concomitant cardiovascular or psychotropic medications.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17023333
003      
CZ-PrNML
005      
20170831103154.0
007      
ta
008      
170720s2017 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.4088/JCP.15m10303 $2 doi
035    __
$a (PubMed)28129493
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Liperoti, Rosa $u Department of Geriatrics, Neuroscience and Orthopedics, Agostino Gemelli University Hospital, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168, Rome, Italy. rossella.liperoti@rm.unicatt.it. Department of Geriatrics, Neuroscience and Orthopedics, Agostino Gemelli University Hospital, Università Cattolica del Sacro Cuore, Rome, Italy.
245    10
$a Antipsychotic Drug Interactions and Mortality Among Nursing Home Residents With Cognitive Impairment / $c R. Liperoti, F. Sganga, F. Landi, E. Topinkova, MD. Denkinger, HG. van der Roest, AD. Foebel, H. Finne-Soveri, R. Bernabei, G. Onder,
520    9_
$a OBJECTIVE: Among elderly individuals with dementia, the use of antipsychotics has been associated with serious adverse events including ischemic stroke and death. Multiple medications can interact with antipsychotics and increase the risk of such adverse events. The purpose of this retrospective, longitudinal cohort study was to estimate the prevalence of potential antipsychotic drug interactions and their effect on increasing the risk of death among cognitively impaired elderly individuals treated with antipsychotics. METHODS: We conducted a retrospective longitudinal cohort study in 59 nursing homes of 7 European Union countries and Israel. The study was conducted during the years 2009 to 2011. Participants were cognitively impaired individuals aged 65 years or older residing in the participating nursing homes and being treated with antipsychotics (N = 604). Risk of death associated with potential antipsychotic drug interactions was the main outcome. The inter-Resident Assessment Instrument for Long Term Care Facilities (interRAI LTCF) was used to assess participants. Follow-up time was 12 months. RESULTS: The prevalence of potential antipsychotic drug interactions was 46.0%. Antipsychotic drug interactions were associated with higher mortality (incidence rate of 0.26 per person-year in the antipsychotic drug-interaction group versus 0.17 per person year in the no antipsychotic drug-interaction group). After adjusting for potential confounders, risk of death was higher in the group of residents with potential antipsychotic drug interactions relative to those unexposed to such interactions (hazard ratio = 1.71; 95% CI, 1.15-2.54). CONCLUSIONS: Part of the observed excess risk of death associated with the use of antipsychotic medications in elderly individuals with cognitive impairment may be attributable to antipsychotic drug interactions. Antipsychotics should be used with extreme caution especially among those individuals receiving concomitant cardiovascular or psychotropic medications.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a Alzheimerova nemoc $x farmakoterapie $x mortalita $7 D000544
650    _2
$a antipsychotika $x škodlivé účinky $x terapeutické užití $7 D014150
650    _2
$a kognitivní dysfunkce $x farmakoterapie $x mortalita $7 D060825
650    _2
$a kohortové studie $7 D015331
650    12
$a lékové interakce $7 D004347
650    _2
$a Evropa $7 D005060
650    12
$a domovy pro seniory $7 D006707
650    _2
$a lidé $7 D006801
650    _2
$a Izrael $7 D007557
650    _2
$a longitudinální studie $7 D008137
650    12
$a pečovatelské domovy $7 D009735
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a riziko $7 D012306
650    _2
$a rizikové faktory $7 D012307
655    _2
$a časopisecké články $7 D016428
700    1_
$a Sganga, Federica $u Department of Geriatrics, Neuroscience and Orthopedics, Agostino Gemelli University Hospital, Università Cattolica del Sacro Cuore, Rome, Italy.
700    1_
$a Landi, Francesco $u Department of Geriatrics, Neuroscience and Orthopedics, Agostino Gemelli University Hospital, Università Cattolica del Sacro Cuore, Rome, Italy.
700    1_
$a Topinkova, Eva $u Department of Geriatrics, First Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Denkinger, Michael D $u AGAPLESION Bethesda Clinic, Competence Centre of Geriatrics, University of Ulm, Ulm, Germany.
700    1_
$a van der Roest, Henriëtte G $u EMGO Institute for Health and Care Research, Department of General Practice and Elderly Care Medicine, VU University Medical Centre, Amsterdam, The Netherlands.
700    1_
$a Foebel, Andrea D $u Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
700    1_
$a Finne-Soveri, Harriet $u Ageing and Services Unit, National Institutes of Health and Welfare (THL), Helsinki, Finland.
700    1_
$a Bernabei, Roberto $u Department of Geriatrics, Neuroscience and Orthopedics, Agostino Gemelli University Hospital, Università Cattolica del Sacro Cuore, Rome, Italy.
700    1_
$a Onder, Graziano $u Department of Geriatrics, Neuroscience and Orthopedics, Agostino Gemelli University Hospital, Università Cattolica del Sacro Cuore, Rome, Italy.
773    0_
$w MED00002601 $t The Journal of clinical psychiatry $x 1555-2101 $g Roč. 78, č. 1 (2017), s. e76-e82
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28129493 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20170831103744 $b ABA008
999    __
$a ok $b bmc $g 1239014 $s 984246
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 78 $c 1 $d e76-e82 $i 1555-2101 $m The Journal of clinical psychiatry $n J Clin Psychiatry $x MED00002601
LZP    __
$a Pubmed-20170720

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace